Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2025)

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 10.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 9,000.00
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 5.00 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Emergent BioSolutions 427.92 Mn 266.42 Mn 84.10 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 38.10 Mn
Mar 31, 2025 38.10 Mn
Dec 31, 2024 300,000.00
Dec 31, 2024 300,000.00
Sep 30, 2024 7.60 Mn
Sep 30, 2024 7.60 Mn
Mar 31, 2012 11.77 Mn
Mar 31, 2012 11.77 Mn